Catching a Moving Target (Q56879898)

https://api.crossref.org/works/10.1126%2FSCIENCE.1210724

Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1210724

Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1210724

Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1210724

Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1210724

Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1210724

Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1210724

A highly conserved neutralizing epitope on group 2 influenza A viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1210724

A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1210724

Naturally occurring human monoclonal antibodies neutralize both 1918 and 2009 pandemic influenza A (H1N1) viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1210724

Clonal dissection of the human memory B-cell repertoire following infection and vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1210724

Wide prevalence of heterosubtypic broadly neutralizing human anti-influenza A antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1210724

Development of human antibody variable genes in systemic autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1210724

V(H)1-69 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1210724

Humoral immune response to ADAMTS13 in acquired thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1210724

Expression of the immunoglobulin VH gene 51p1 is proportional to its germline gene copy number

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1210724

Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1210724

Characterization of molecular features, antigen-binding, and in vitro properties of IgG and IgM variants of 4E10, an anti-HIV type 1 neutralizing monoclonal antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1210724

Induction of broadly neutralizing H1N1 influenza antibodies by vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1210724

Seasonal influenza infection and live vaccine prime for a response to the 2009 pandemic H1N1 vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1210724

Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1210724

Universal antibodies against the highly conserved influenza fusion peptide cross-neutralize several subtypes of influenza A virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1210724